000 04091nam a22003975i 4500
999 _c368683
_d368683
_x1
001 368683
003 ES-MaUEC
005 20230102121758.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 220101s2022 sz | s |||| 0|eng d
020 _a9783030827908
024 7 _a10.1007/978-3-030-82790-8
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRM302
_b2022 EB
100 _aPatsalos, Philip N.
_999313
245 1 0 _aAntiseizure Medication Interactions :
_bA Clinical Guide
_cby Philip N. Patsalos
250 _aFourth edition 2022
264 1 _aCham
_bSpringer International Publishing,
_c2022
300 _a1 recurso en línea (XV, 357 páginas)
_b32 ilustraciones
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aarchivo de texto
_bPDF
505 0 _aSection 1 - Introduction -- Section 2 - Drug Interactions Between AEDs -- Acetazolamide -- Cannabidiol -- Carbamazepine -- Clobazam -- Clonazepam -- Ethosuximide -- Eslicarbazepine acetate -- Felbamate -- Fenfluramine -- Gabapentin -- Lacosamide -- Lamotrigine -- Levetiraceta -- Methsuximide -- Oxcarbazepine -- Perampanel -- Phenobarbital -- Phenytoin -- Piracetam -- Pregabalin -- Primidone -- Rufinamide -- Stiripentol -- Tiagabine -- Topiramate -- Valproic Acid -- Vigabatrin -- Zonisamide -- Section 3 - Drug Interactions between AEDs and non-AED drugs: Interactions Affecting AEDs -- Acetazolamide -- Cannabidiol -- Carbamazepine -- Clobazam -- Clonazepam -- Ethosuximide -- Eslicarbazepine acetate -- Felbamate -- Fenfluramine -- Gabapentin -- Lacosamide -- Lamotrigine -- Levetiracetam -- Methsuximide -- Oxcarbazepine -- Perampanel -- Phenobarbital -- Phenytoin -- Piracetam -- Pregabalin -- Primidone -- Rufinamide -- Stiripentol -- Tiagabine -- Topiramate -- Valproic Acid -- Vigabatrin -- Zonisamide -- Section 4 - Drug Interactions between AEDs and non-AED drugs: Interactions Affected by AEDS -- Analgesics -- Antimicrobials -- Antineoplastic agents -- Antiulcer drugs -- Cardiovascular drugs -- Immunosuppressants -- Neuromuscular Blocking Agents -- Psychotropic Drugs -- Steroids -- Miscellanea. .
520 _aThis significantly revised fourth edition provides a practically orientated guide to interactions associated with antiseizure medications. It describes pharmacokinetic and pharmacodynamic antiseizure medication (ASM) interactions, including details of the magnitude and mechanism of interactions, and also of drug combinations that are not associated with interactions and therefore can be co-prescribed without undue concern. Presented in alphabetical order and by drug class, drug interactions that occur between ASMs and also between ASMs and non- ASMs are described in three sections: Drug interactions between ASMs; Drug interactions between ASMs and non- ASM Drugs: Interactions affecting ASMs; Drug interactions between ASMs and non ASM Drugs: Interactions affected by ASMs. The latest data on all drug interactions is presented. New agents discussed include cannabidiol, cenobamate, everolimus and fenfluramine,. Antiseizure Medication Interactions: A Clinical Guide, 4th Edition concisely presents the most recent developments and data available on the topic. Therefore, enabling physicians and allied health professionals to make more rational choices when ASM polytherapy regimens are required. It will be of interest to medical professionals in disciplines including neurology, psychiatry and pediatrics.
988 _aSpringer_Medicine_2022
650 7 _2embne
_9137892
_aMedicamentos
_xInteracción
776 0 8 _iPrinted edition:
_z9783030827892
776 0 8 _iPrinted edition:
_z9783030827915
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-82790-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0
998 _b04/2022
_dz
_eh
_zSI